Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-07-12
2011-10-11
Graser, Jennifer (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S185100, C424S190100, C424S234100, C435S069100, C435S069300, C435S071100, C530S300000, C530S350000
Reexamination Certificate
active
08034358
ABSTRACT:
The invention provides a novel surface polypeptide fromNeisseria meningitidisas well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis ofN. meningitidisinfection.
REFERENCES:
patent: 4702911 (1987-10-01), McMichael
patent: 4769240 (1988-09-01), Brinton
patent: 5618541 (1997-04-01), Quentin-Millet
patent: 5646259 (1997-07-01), St. Geme, III
patent: 6197312 (2001-03-01), Peak
patent: 6495345 (2002-12-01), Peak
patent: 6607729 (2003-08-01), Peak
patent: 6709660 (2004-03-01), Scarlato
patent: 6780419 (2004-08-01), Ruelle
patent: 0 301 992 (1989-02-01), None
patent: WO 92/03467 (1992-03-01), None
patent: WO 93/06861 (1993-04-01), None
patent: WO 96/29412 (1996-09-01), None
patent: WO 97/26359 (1997-07-01), None
patent: WO 99/31132 (1999-06-01), None
patent: WO 99/58683 (1999-11-01), None
Stephen J. Barenkamp and Joseph W. St. Geme III, “Identification of a Second Family of High-molecular-Weight Adhesion Proteins Expressed by Non-TypableHaemophilus Influenzae,” Molecular Microbiology, 1996, 19(6), pp. 1215-1223.
Feng et al., “J. Mol. Evol.” 25: 351-380, 1987.
Higgins et al., Cabios Communications 5(2): 151-153, 1989.
Hopp et al., Molecular Immunology 20(4): 483-489, 1983.
Kolaskar et al., FEBS 276(1,2): 172-174, 1990.
Welling et al., FEBS 188(2): 215-218, 1985.
Sacchi et al., “Considerations on the Use ofNeisseria meningitidisClass 5 Proteins as Meningococcal BC Vaccine Components,”Vaccine, 1995, vol. 13, No. 1, pp. 112-118, Elsevier Science Ltd.
Rudinger et al., in “Peptide Hormones,” edited by Parsons, J.A., University Park Press, Jun. 1976, p. 6.
Burgess et al., The Journal of Cell Biology, 111:2129-2138, 1990.
Lazar et al., Molecular and Cellular Biology, 8(3):1247-1252, 1988.
Jobling et al., Mol. Microbiol. 1991, 5(7): 1755-67.
St. Geme et al., Characterization of the Genetic Locus Encoding Haemophilus Influence Type B Surface Fibrils, J. Bacteriol., Nov. 1996, pp. 6281-6287, vol. 178, No. 21.
Jennings Michael Paul
Moxon E. Richard
Peak Ian Richard Anselm
Graser Jennifer
Perkins Coie LLP
The University of Queesland
LandOfFree
Surface antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Surface antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surface antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4298733